Baton Rouge, Louisiana
7 Day Forecast
Follow our weather team on social media

Lawmakers anxious to hear from Shkreli, but he's taking 5th

7 years 1 month 2 weeks ago Thursday, February 04 2016 Feb 4, 2016 February 04, 2016 10:30 AM February 04, 2016 in News
Source: Associated Press
By: APnewsNow

WASHINGTON - U.S. lawmakers are anxious to hear from 32-year-old pharmaceutical chief Martin Shkreli about severe hikes for a drug sold by a company that he acquired.

But it's unlikely the former CEO of Turing Pharmaceuticals will answer questions in his appearance Thursday before the House Oversight and Government Reform Committee. Shkreli, who has been widely scorned for hiking the price of a long-established and potentially lifesaving drug by more than 5,000 percent, says he's exercising his Fifth Amendment right against self-incrimination.

Shkreli is facing separate criminal charges of securities fraud related to another drug company.

Also going before lawmakers is the interim CEO of Canada's largest drugmaker, Valeant Pharmaceuticals. Both companies have bought and sharply raised prices for drugs taken by patients with heart problems, AIDS, cancer and other conditions.

More News

Desktop News

Click to open Continuous News in a sidebar that updates in real-time.
7 Days